Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sawai Group Holdings CoSWGHF 53 EV-to-OCF is 37.53 as of Aug. 05, 2026, which is 142% above its 10-year median of 15.51. GuruFocus rates SWGHF with a GF Score™ of 53/100 and a GF Value™ of $15.98. The stock has 3 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Sawai Group Holdings Co ranks worse than 83.33% on this metric.
The historical rank and industry rank for Sawai Group Holdings Co's EV-to-OCF or its related term are showing as below:
SWGHF'
s EV-to-OCF Range Over the Past 10 Years
Min: 5.72 Med: 15.51 Max: 46.04
Current: 35.97
During the past 5 years, the highest EV-to-OCF of Sawai Group Holdings Co was 46.04. The lowest was 5.72. And the median was 15.51.
SWGHF's EV-to-OCF is ranked worse than 83.33% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 10.825
vs SWGHF: 35.97
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sawai Group Holdings Co (OTCPK:SWGHF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sawai Group Holdings Co's PE Ratio (TTM) for today is calculated as:
Sawai Group Holdings Co's share price for today is $11.52.
Sawai Group Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.602.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's EV-to-OCF falls into.
Sawai Group Holdings Co's current Enterprise Value is $1,666 Mil.
Sawai Group Holdings Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co (SWGHF) has a EV-to-OCF of 37.53 as of Aug. 05, 2026. This is 142% above median its historical median of 15.51. Over the past decade, Sawai Group Holdings Co's EV-to-OCF has ranged from 5.72 to 46.04. According to the industry distribution chart, Sawai Group Holdings Co ranks #840 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 83.3%.
Is Sawai Group Holdings Co's EV-to-OCF too high?
Sawai Group Holdings Co's current EV-to-OCF of 37.53 is 142% above median its 10-year median of 15.51. Over the past 10 years, this metric has ranged from a low of 5.72 to a high of 46.04. The Drug Manufacturers industry median EV-to-OCF is 10.83. Sawai Group Holdings Co's value of 37.53 is 246.7% above this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #840 out of 1008 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sawai Group Holdings Co has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #840 out of 1008 companies for EV-to-OCF. This places Sawai Group Holdings Co in the lower half of its industry. The industry median EV-to-OCF is 10.83. Sawai Group Holdings Co's value of 37.53 is 246.7% above this benchmark. Historically, Sawai Group Holdings Co's own EV-to-OCF has ranged from 5.72 to 46.04 over the past decade. While the company's 10-year median is 15.51 vs. the industry median of 10.83, Sawai Group Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.83, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current EV-to-OCF of 37.53 is 246.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current EV-to-OCF is 37.53, which is 142% above median its own 10-year median of 15.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Sawai Group Holdings Co (SWGHF) has a current EV-to-OCF of 37.53. The stock's GF Value™ is $15.98, compared to a current price of $11.52 — trading 27.9% below its estimated fair value. The current EV-to-OCF is 37.53, which is 142% above median its 10-year median of 15.51 and 246.7% above the Drug Manufacturers industry median of 10.83. Sawai Group Holdings Co's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Sawai Group Holdings Co (SWGHF), the current EV-to-OCF is 37.53 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (SWGHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of $11.52 is trading 27.9% below its estimated GF Value™ of $15.98.
Key valuation signals for SWGHF:
EV-to-OCF: 37.53 (142% above median its 10-year median of 15.51)
GF Value™: $15.98 vs. price of $11.52 (27.9% below fair value)
Industry Position: 246.7% above the Drug Manufacturers median (#840 of 1008)
No single metric tells the full story. See the SWGHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
53GF Score
Get the complete analysis for SWGHF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SWGHF has been successfully added to your 
